ARA-290ARA-290
At a glance
A peptide derived from erythropoietin, studied for nerve repair and reducing inflammation.
ARA-290, also known as cibinetide, is an experimental peptide developed from a region of erythropoietin (EPO) and researched for its potential tissue-protective and anti-inflammatory effects. It is designed to activate a specific receptor involved in tissue protection and inflammatory signalling without producing the same red-blood-cell-stimulating effects associated with EPO. Researchers have investigated its potential role in nerve health, neuropathic pain, and conditions involving inflammation or tissue damage. Early clinical research has explored its effects in certain forms of small-fibre neuropathy, generating interest in its possible applications in nerve-related conditions. Its mechanism makes it a subject of research into tissue protection and inflammatory regulation. However, further studies are needed to establish its effectiveness and long-term safety across different conditions. ARA-290 remains investigational and is not an established treatment for nerve damage or inflammation.
Order this product
Message us on WhatsApp at 07361 793324 or email rawpeptides@outlook.com with the product name and quantity. We'll confirm payment and delivery by reply.
Add a starter pack to any order for £10. Just mention it in your message.
Sold for research use only. Not for human consumption. Not for veterinary use.
Product details
Purity
99%+
Size
10mg
Form
Lyophilised Powder
Testing
On request
- Over 99% purity
- Sealed research vial
- Boxed with blister pack
- Store between 2°C and 8°C

